Yearly Archives: 2021

Impact of International Reference Pricing on Drug Innovation

By Denise Bell | Published April 9, 2021

Policymakers in Washington are considering plans to replace the current market-based system for pricing prescription medicines with a system based on foreign reference pricing. If enacted, this policy will import to the US price controls that foreign countries use to deny patients access to the newest cures and treatments. It could also impede innovation and […]

Posted in Policy News | Leave a comment

The Element Awards 2021: LIfe Sciences Women in Business Honored

By Denise Bell | Published April 2, 2021

The St. George Area Chamber of Commerce hosted the First Annual Element Awards recognizing sixteen outstanding women of achievement in Washington County. The inaugural event was held March 26 at the Dixie Convention Center. These women, including women on the front lines of the life sciences, are building a legacy that future generations will emulate […]

Posted in BioUtah News | Leave a comment

BioHive Spotlight: Jeffery Nelson, Nelson Labs

By admin | Published March 19, 2021

Nelson Labs started in Utah and has grown under the leadership of Jeffery Nelson, Chairman of Nelson Labs. BIoHive turns the spotlight on Jeffery in this video as he talks about the company, its contributions to the life sciences industry and what it means to be a part. of BioHive. Nelson is “helping those innovators, […]

Posted in BioUtah News | Leave a comment

FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

By Denise Bell | Published March 19, 2021

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]

Posted in BioUtah News, COVID-19 Updates, HHS/FDA & Other Regulatory, Utah's Life Sciences Companies | Leave a comment

Utah Legislature Appropriates $600,000 to support BioHive initiative

By admin | Published March 11, 2021

On the last day of the Utah legislative session, the legislature passed SB 2 “New Fiscal Year Supplemental Appropriations Act”. Among the items funded was $600,000 to support the BioHive branding initiative. In SB 3 entitled “Appropriations Adjustments” the language makes clear that the amount of the $600,000 to be released is dependent on 1:1 matching from […]

Posted in BioUtah News | Leave a comment

President Biden Signs $1.9 Trillion COVID-19 Relief Bill

By Denise Bell | Published March 11, 2021

Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package that Congress approved this week. On Wednesday, the House of Representatives approved the Senate-passed version of the bill by a vote of 220 to 211, with one Democrat joining all Republicans in voting against it. Rep. Jared […]

Posted in COVID-19 Legislation, Federal News, Policy News | Leave a comment

Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations

By Denise Bell | Published March 11, 2021

Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, TX where Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, Endourology, and Endoscopy markets. The Texas expansion totals 24,000 sq. ft. including […]

Posted in BioUtah News, Utah's Life Sciences Companies | Comments Off